x
Visit our new Mobile Website next time you access NetDania with your mobile device

Y-MABS THERAPEUTICS INC. - COMMON STOCK

15.21
30-19:59:58 GMT
-0.29
-1.87%
ISIN:N/A

Figures - Y-MABS THERAPEUTICS INC. - COMMON STOCK

Open
15.29
Close
15.50
Year Change
123.02
Year % Change
+123.02%
52 Week High
20.90
52 Week Low
4.60
Volume
214271
Inc. Vol
36171

News - Y-MABS THERAPEUTICS INC. - COMMON STOCK

01-02:54 GMT
Real Estate Scams Are On The Rise. Here’s What You Need To Know
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:54 GMT
Japanese Market Significantly Lower
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:54 GMT
Amazon.com (AMZN) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:54 GMT
Skyworks Solutions (SWKS) Q2 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:48 GMT
How To Create A Formula For Owning The Inclusive Leadership Journey
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:48 GMT
Tax Rates Are Falling, But Rising Insurance Rates Remain A Challenge
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:26 GMT
FDA Approves Neurocrine Biosciences' INGREZZA Sprinkle Capsules
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:20 GMT
How Ravi Kishan Forgot Lines But Delivered Comedy In ‘Mamla Legal Hai’
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:15 GMT
A 2024 Report Reveals Small Business Marketing Challenges
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:11 GMT
The European Union Moves To Crackdown On Foreign Drivers
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:02 GMT
Shake Shack to open its first Canadian location in Toronto this summer
Source: FinancialPost-TopStories, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-02:02 GMT
AI Craze, LNG Exports Offer Hope For America’s Gas Producers
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:57 GMT
Keys To Managing Small Business Growth Without Major Investors
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:57 GMT
AI Will Transform The Federal Government Sooner Than You Think
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:57 GMT
Australian Market Sharply Lower
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:49 GMT
This Rome Luxury Hotel Wants You To Book A Supercar With Your Stay
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:49 GMT
Rockets General Manager Rafael Stone Finishes Fifth In Executive Of The Year Award Voting
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:46 GMT
Tax Cuts Pass In Multiple States In April, With More In Store For May
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:37 GMT
Unlock Liquidity: Key Tactics For Managing Cash Flow
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:36 GMT
Roger Ver, Known As “Bitcoin Jesus,” Arrested And Charged With Tax Fraud
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:32 GMT
Chinese women are partnering with strangers to save money
Source: BBCBusiness, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:30 GMT
Why SiriusXM Radio Stock Was Falling Today
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:28 GMT
India's economy: The good, bad and ugly in six charts
Source: BBCBusiness, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:27 GMT
School Vouchers Have A Transparency Problem
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:13 GMT
IBM Has a Healthy 4% Dividend Yield, But Is the Stock a Buy?
Source: NASDAQ Stocks, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:12 GMT
Milwaukee Bucks’ Season Has Been A Roller Coaster Since The Beginning
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:09 GMT
Beyoncé’s Guide To Legacy: 3 Steps To Make Your Mark
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:06 GMT
ChatGPT And The Battleground To Recreate A Paid Market For Knowledge
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:03 GMT
Advanced Micro Devices (AMD) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
01-01:02 GMT
In A Rising Tide Of College Closures, Impact On Division III Athletics Becomes Clear
Source: Forbes World, Symbol: Y-MABS THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
37854.22
48.1
0.13%
5037.60
9.09
0.18%
17421.05
19.21
0.11%
60202.00
-634
-1.04%
17965.38
-229.66
-1.26%
38256.20
130.02
0.34%
3104.82
-8.22
-0.26%
8157.07
5.92
0.07%
17595.91
-172.66
-0.97%
7584.89
7.43
0.10%
22604.85
-38.55
-0.17%
2287.95
-3.35
-0.15%
85.58
-0.36
-0.42%
1.06582
-0.00077
-0.07%
157.892
0.153
0.10%
1.24801
-0.00085
-0.07%
0.64704
-0.00041
-0.06%
1.37765
-0.00009
-0.01%
168.30900
0.041
0.02%
0.85397
-0.00004
0.00%
197.05200
0.054
0.03%
0.92016
0.00053
0.06%
0.98075
-0.00013
-0.01%
0.58863
0.00091
0.15%
106.39300
0.088
0.08%
Top Gainers
Name
Last
+/-
%
0.70
0.39
125.08%
14.88
6.56
78.85%
0.40
0.17
70.28%
0.02
0.01
67.69%
0.26
0.10
60.00%
1.48
0.55
59.09%
2.12
0.76
55.88%
17.07
6.07
55.18%
3.18
1.08
51.43%
0.01
0.00
48.08%
Top Losers
Name
Last
+/-
%
0.00
-0.01
-59.60%
0.10
-0.12
-54.76%
0.01
0.00
-41.44%
0.23
-0.15
-38.58%
0.02
-0.02
-37.50%
1.14
-0.64
-35.96%
0.08
-0.04
-34.61%
0.10
-0.05
-32.08%
1.38
-0.65
-32.02%
0.01
-0.01
-30.30%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy